Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(17%)

Phase Distribution

Ph phase_1
1
17%
Ph phase_2
3
50%
Ph phase_3
1
17%
Ph phase_4
1
17%

Phase Distribution

1

Early Stage

3

Mid Stage

2

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
1(16.7%)
Phase 2Efficacy & side effects
3(50.0%)
Phase 3Large-scale testing
1(16.7%)
Phase 4Post-market surveillance
1(16.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Completed(3)
Terminated(1)
Other(2)

Detailed Status

Completed3
unknown2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
75.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (16.7%)
Phase 23 (50.0%)
Phase 31 (16.7%)
Phase 41 (16.7%)

Trials by Status

terminated117%
unknown233%
completed350%

Recent Activity

0 active trials
Showing 5 of 6
terminatedphase_4

Manidipine Versus Amlodipine in Patients With Hypertension

NCT03106597
completedphase_3

Trial to Evaluate the Efficacy and Safety of a Combination Therapy of Candesartan and Amlodipine Versus Candesartan Monotherapy in Hypertensive Patients Inadequately Controlled by Candesartan Monotherapy

NCT02651870
completedphase_2

Comparison of Efficacy and Safety of Combination Therapy and Monotherapy of Candesartan and Amlodipine for Dose-Finding in Patients With Essential Hypertension

NCT02944734
unknownphase_2

A Dose Selection Trial of CKD-330 in Patients With Essential Hypertension

NCT02206165
completedphase_1

CKD-330 Drug-Drug Interaction Study (Amlodipine)

NCT02064556
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT03106597Phase 4

Manidipine Versus Amlodipine in Patients With Hypertension

Terminated
NCT02651870Phase 3

Trial to Evaluate the Efficacy and Safety of a Combination Therapy of Candesartan and Amlodipine Versus Candesartan Monotherapy in Hypertensive Patients Inadequately Controlled by Candesartan Monotherapy

Completed
NCT02944734Phase 2

Comparison of Efficacy and Safety of Combination Therapy and Monotherapy of Candesartan and Amlodipine for Dose-Finding in Patients With Essential Hypertension

Completed
NCT02206165Phase 2

A Dose Selection Trial of CKD-330 in Patients With Essential Hypertension

Unknown
NCT02064556Phase 1

CKD-330 Drug-Drug Interaction Study (Amlodipine)

Completed
NCT02059616Phase 2

A Phase 2 Dose Selection Trial of Candesartan Cilexetil and Amlodipine Besylate to Treat Essential Hypertension

Unknown

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6